| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-06 |
| mRNA |
CGP-082996 |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
4e-05 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
MS-275 |
FIMM |
pan-cancer |
AAC |
0.45 |
0.0001 |
| mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0002 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
| mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |